Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary reinfusion of autologous bone marrow mononuclear cells in acute myocardial infarction
2012-001495-11Phase 3Completed
- Sponsor
- Queen Mary University of London
- Start
- Mar 2013
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised trial of autologous bone marrow-derived mononuclear cell in myocardial infarction (MI) (2 arms), sponsored by Queen Mary University of London. Primary endpoint: Time from randomisation to all-cause death. Started Mar 2013; status: completed.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2012-001495-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001495-11.